Chat with us

Empagliflozin 10mg, Sitagliptin 100mg - Steris Pha...

Empagliflozin 10mg, Sitagliptin 100mg - Steris Pharma

GLIEMPAFLOZIN SITA 10/100 is a combination medication designed to effectively manage type 2 diabetes. This innovative formula combines two potent ingredients: Empagliflozin 10mg and Sitagliptin 100mg. Together, these active ingredients work synergistically to help control blood sugar levels, improve insulin sensitivity, and support overall metabolic health. This medication offers a comprehensive approach to diabetes management, addressing both blood glucose regulation and insulin production.

Introduction

Managing type 2 diabetes requires a multifaceted approach, which often includes medications to control blood sugar levels, a healthy diet, and regular physical activity. GLIEMPAFLOZIN SITA 10/100 combines two powerful mechanisms to help individuals with type 2 diabetes achieve better glucose control. This combination medication provides the benefits of Empagliflozin, an SGLT2 inhibitor, and Sitagliptin, a DPP-4 inhibitor, both of which contribute to improved blood sugar regulation in different ways.

Empagliflozin 10mg works by preventing the reabsorption of glucose in the kidneys, allowing it to be excreted through the urine. On the other hand, Sitagliptin 100mg enhances the body’s natural insulin production and helps reduce the amount of glucose produced by the liver. By combining these two active ingredients, GLIEMPAFLOZIN SITA 10/100 provides a more comprehensive and effective solution for managing type 2 diabetes.

Key Features and Ingredients

GLIEMPAFLOZIN SITA 10/100 combines two important ingredients, each with distinct roles in managing blood glucose levels:

Empagliflozin 10mg: Empagliflozin is an SGLT2 inhibitor that works by blocking the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. This action prevents glucose from being reabsorbed into the bloodstream, allowing it to be excreted through urine. This reduces blood sugar levels and also has the added benefit of aiding in weight loss and lowering blood pressure.
Sitagliptin 100mg: Sitagliptin is a DPP-4 inhibitor that helps regulate insulin production. It works by inhibiting the enzyme DPP-4, which breaks down GLP-1 (glucagon-like peptide-1). By preventing the breakdown of GLP-1, Sitagliptin enhances insulin secretion in response to meals and reduces the production of glucose by the liver, leading to better blood sugar control.

Together, these two ingredients offer complementary benefits for controlling blood glucose levels, reducing complications, and improving overall diabetes management.

Usage

GLIEMPAFLOZIN SITA 10/100 is typically prescribed for adults with type 2 diabetes who are not adequately controlled on diet and exercise alone or who need additional glucose-lowering therapy. It is used in combination with a healthy diet and regular physical activity to help lower blood sugar levels and improve insulin sensitivity.

Dosage Instructions

The usual recommended dosage is 1 tablet per day, taken with or without food.
The dosage should be taken as directed by a healthcare provider. Do not exceed the prescribed dose.
It is important to take the medication regularly to maintain consistent blood sugar control.

Precautions

Before starting GLIEMPAFLOZIN SITA 10/100, inform your doctor if you have any pre-existing kidney, liver, or heart conditions, as these may affect the way the medication works.
Regular monitoring of kidney function and blood sugar levels is important while taking this medication.
If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before using this medication.

Benefits of GLIEMPAFLOZIN SITA 10/100

The combination of Empagliflozin and Sitagliptin in GLIEMPAFLOZIN SITA 10/100 offers numerous benefits for individuals living with type 2 diabetes:

Improved Blood Sugar Control: By combining the effects of Empagliflozine and Sitagliptin, GLIEMPAFLOZIN SITA 10/100 provides dual action in managing blood glucose levels. Empagliflozin helps lower glucose by promoting its excretion through the urine, while Sitagliptin enhances insulin secretion and reduces liver glucose production.
Weight Loss: Empagliflozin contributes to weight loss by promoting the excretion of glucose, which reduces the overall calorie content in the body. This weight loss benefit is particularly helpful for individuals with type 2 diabetes, as excess weight can worsen blood sugar control.
Lower Blood Pressure: One of the benefits of Empagliflozin is its ability to reduce blood pressure. This effect can be beneficial for diabetic patients who may also suffer from hypertension, improving cardiovascular health.
Enhances Insulin Sensitivity: Sitagliptin works by increasing the levels of GLP-1, which enhances insulin sensitivity and helps maintain normal blood sugar levels after meals. This is crucial for those with insulin resistance, which is a hallmark of type 2 diabetes.
Reduced Risk of Heart Disease: Empagliflozin has been shown to provide heart-protective benefits. It reduces the risk of cardiovascular events such as heart attacks and strokes in people with type 2 diabetes, which is critical for improving long-term health outcomes.
Convenient Once-Daily Dosing: The once-daily dosing of GLIEMPAFLOZIN SITA 10/100 makes it easy for patients to incorporate it into their daily routine. The extended-release formulation ensures consistent effectiveness throughout the day.
Complementary Mechanisms of Action: The combined action of Empagliflozin and Sitagliptin addresses different aspects of type 2 diabetes—from glucose excretion to insulin secretion—making this medication highly effective for comprehensive blood sugar management.

Conclusion

GLIEMPAFLOZIN SITA 10/100 offers a highly effective and convenient treatment for managing type 2 diabetes. The combination of Empagliflozin 10mg and Sitagliptin 100mg provides dual-action therapy, improving blood glucose control, enhancing insulin sensitivity, promoting weight loss, and supporting cardiovascular health. This comprehensive medication is particularly beneficial for those who need additional help in managing their blood sugar levels alongside diet and exercise.Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma's product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.